Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MacroGenics Inc MGNX

Healthcare Biotechnology
MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor... see more

Recent & Breaking News (NDAQ:MGNX)

The Schall Law Firm Has Begun Probing Allegations Against MacroGenics, Inc. (MGNX) And Is Encouraging Its Investors To Make Contact

Accesswire June 11, 2024

MacroGenics to Participate in Upcoming Investor Conference

GlobeNewswire June 11, 2024

MacroGenics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - MGNX

Accesswire June 10, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX

Accesswire June 9, 2024

The Schall Law Firm has initiated an investigation into claims against MacroGenics, Inc. (MGNX) and is urging its investors to reach out

Accesswire June 9, 2024

ATTENTION MacroGenics, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

Accesswire June 8, 2024

Investors who lost money on MacroGenics, Inc. should contact Levi & Korsinsky about an ongoing investigation - MGNX

Accesswire June 8, 2024

The Schall Law Firm has begun a probe into allegations against MacroGenics, Inc. (MGNX) and encourages its investors to make contact

Accesswire June 8, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX

PR Newswire June 7, 2024

MacroGenics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - MGNX

Accesswire June 7, 2024

The Schall Law Firm has initiated an investigation into claims against MacroGenics, Inc. (MGNX) and is urging its investors to reach out

Accesswire June 7, 2024

MacroGenics, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - MGNX

Accesswire June 6, 2024

The Schall Law Firm Begins Inquiry Into Allegations Against MacroGenics, Inc. (MGNX) And Encourages Its Investors To Make Contact

Accesswire June 6, 2024

Investors who Lost Money on MacroGenics, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - MGNX

Accesswire June 5, 2024

The Schall Law Firm Initiates Investigation Into Claims Against MacroGenics, Inc. (MGNX) And Calls For Investors To Reach Out

Accesswire June 5, 2024

Lost Money on MacroGenics, Inc. (MGNX)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky

Accesswire June 4, 2024

The Schall Law Firm Launches Inquiry into Allegations Against MacroGenics, Inc. and Encourages Investors to Communicate

Accesswire June 4, 2024

MGNX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your MacroGenics, Inc. Investment

Accesswire June 4, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX

Newsfile June 3, 2024

MGNX CRUCIAL INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and Encourages Investors to Contact the Firm

Accesswire June 3, 2024